Curapath is a new, bigger vision for our future. We will have the same great services and an even better look! Watch this space for the upcoming transition.

What we do

PTS is a technology-focused company specializing in the design and manufacturing of nanoparticle delivery systems leveraging our technical expertise in custom polymer, lipid, and polyamino acid synthesis.  PTS’s capabilities support our partner’s therapeutic programs from discovery, clinical development, and product commercialization.

PTS is a leader in the Design, Development & Custom Manufacturing of Drug Substances (DS) and Drug Products (DP) related to advanced drug delivery systems. Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, cGMP Manufacturing and aseptic Fill & Finish.



Polyamino Acid Design & Functional Proof of Concept

Our team will provide your team an extensive knowledge on polymer-biology interface to design technologies specially suited for delivering Nucleic Acids, Small Drugs and Proteins.

Process Development & Preclinical Batches

Flexible and agile approach to develop robust and reproducible processes to meet your specific product requirements for GLP TOX studies.

GMP production & regulatory support

We offer an integral solution to bring your developments from preclinical to GMP manufacturing including our support on regulatory affairs & CMC-DMF documentation.

Analytical Development & QC

Our QC scientists support the development of Drug Substances through the entire project life-cycle within GMP & GLP Certified Lab and qualified equipment. Equipment and skills are specially suited but not limited to method development, validation and stability studies.



Proyecto de inversión INPYME 2022

Polypeptide Therapeutic Solutions, S.L. ha llevado a cabo en 2022 un importante proyecto de inversión subvencionado con 41.164,48 € por la Conselleria d’Economia Sostenible, Sectors Productius, Comerç i Treball a través del expediente INPYME/2022/1009 dentro de la convocatoria de ayudas INPYME 2022.   Con la subvención de:

Polypeptide Therapeutics Solutions (PTS) Announces Company Name Change to Curapath and Expansion of Drug Delivery Capabilities and Services

Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation Addition of late stage clinical and commercial-scale production is also planned Company to present on shielding lipid novel excipients for lipid nanoparticle (LNP) formulations at Lipid Nanoparticles Development Summit on October 20th Valencia, Spain and Boston, MA, October 17, 2022 –…

Proyecto CDTI: Investigación de una nueva vacuna para una enfermedad respiratoria humana

Hipra Scientific S.L.U, Polypeptide Therapeutic Solutions S.L., Biotechvana S.L. y Nostrum Biodiscovery constituyen el consorcio de empresas que participan en el proyecto “Investigación de una nueva vacuna para una enfermedad respiratoria humana”, subvencionado por el CDTI (Centro para el Desarrollo Tecnológico Industrial), apoyado por el Ministerio de Ciencia e Innovación y financiado por la Unión Europea…


Contract Pharma

The 21st Annual Contracting & Outsourcing Conference & Tabletop Exhibition will be held September 22-23, 2022 at Hyatt Regency New Brunswick, NJ, located in the heart of New Jersey’s pharmaceutical industry. The two-day conference and one-day exhibition on September 22nd provides the perfect venue for easy, informal discussions for manufacturing, packaging, laboratory services and more! The tabletop exhibition will be…

European LNP

The LNP Development Europe Summit is the only European conference solely dedicated to LNP formulation and process development to enable seamless scale-up, keeping GMP compliance and manufacturing in mind. Given the rapid developments in the field and the success of Pfizer / BioNTech’s mRNA vaccine, lipid nanoparticles have finally reached an inflection point. With new technologies and advancements, LNPs are now a commercially viable delivery vehicle with clinical utility.  We have…

Next Generation LNPs

The Next Generation Lipid-Based Nanoparticles Delivery Summit is your definitive industry-led meeting to design and engineer 2nd generation of lipid nanoparticles for emerging payloads beyond RNA into clinic. Join Intellia Therapeutics, Entos Pharmaceuticals, AstraZeneca, Eli Lilly, and other scientific trailblazers as they navigate the next generation of lipid-based nanoparticles for  targeted delivery to expedite innovative treatments for unmet patient needs.

CRS 2022

The conference theme this year is “Advanced Delivery Science”, which reflects their focus on cutting-edge research and innovation across our strong discipline that will keep you up-to-date with new science and inspire new ideas. Most importantly, this event will offer you the ability to meet in-person for the first time since 2019, to network, form…

DDF Summit

The 2022 Summit covers small molecules and biologics, new technologies, concepts and case studies in areas such as: Formulation design for poorly soluble compounds The potential of nanotechnology for better deliverability The latest controlled released technologies Improving patient compliance by harnessing data and the latest smart device technology Optimising formulations for continuous manufacturing Overcoming the blood brain barrier and challenges in oral delivery of biologics Reformulation and biosimilars

Contact us